Challenges in Chagas Disease Drug Development
The protozoan parasite <i>Trypanosoma cruzi</i> causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been...
Main Authors: | Amanda F. Francisco, Shiromani Jayawardhana, Francisco Olmo, Michael D. Lewis, Shane R. Wilkinson, Martin C. Taylor, John M. Kelly |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/12/2799 |
Similar Items
-
Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease
by: Amanda Fortes Francisco, et al.
Published: (2023-11-01) -
Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery
by: Felipe Raposo Passos Mansoldo, et al.
Published: (2020-11-01) -
Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
by: Ana Catarina Cristovão Silva, et al.
Published: (2019-08-01) -
Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
by: Jean-Yves Brossas, et al.
Published: (2021-11-01) -
Chagas, a lógica e a descoberta Chagas, the logic and the discovery
by: François Delaporte
Published: (1995-02-01)